New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and ...

Liv Hospital integrates PET/CT diagnostics, radionuclide therapies and a multidisciplinary council to create individualized treatment plans for complex cancer and cardiac cases.

New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society ...

Cyclotrons have fundamentally transformed nuclear medicine and cancer therapy over the past decade, with major milestones driven by Best ABT, Best Cyclotron Systems (BCS) and TeamBest Global (TBG), ...

Positron is committed to expanding the cardiac and oncology PET modality by delivering the best technology and value to imaging specialists and will continue to advance its technology through its ...

In this exclusive MedPage Today video, Specht is joined via Zoom by study co-lead, Heather Jacene, MD, of Brigham and Women's ...

The study published in JAVMA highlights a critical lack of veterinary-specific data on PET/CT radiation exposure.

SynuSight Biotech has licensed 18 F-FD4 to XingImaging and to ABLi Therapeutics to evaluate alpha-synuclein clearance from the brain in response to risvodetinib treatment . SHANGH ...

Positron ( ($POSC) ) has provided an update. On December 30, 2025, Positron Corporation announced it had raised $2 million through the issuance of ...

The ability to follow patients with this high sensitivity allows us to make a more accurate and precise measurement, and we can see small changes or see them in a shorter period of time…,” ...

Starting in the first quarter of 2026, Rwanda is set to become a producer of radionuclides, a key chemical for nuclear medicine.